CRMDCorMedix Inc.

CRMD Stock Price, Valuation & Chart | CorMedix Inc.

Compare

$8.610+0.23 (+2.74%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology CRMD intrinsic value CRMD calculated fair value vs price

Overview Financials Dividends Ratios

CRMD Historical price chart

CRMD Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization675.47M

PE Ratio4.56

EPS1.89

Trading Volume1.10M

Today's High/Low8.62/8.34

Dividend Yield0.00

52 Week High/Low14.66/6.13

Shares Outstanding78.45M

CRMD Financial Statement

CRMD Analyst ratings

CRMD Analysis & performance metrics

CRMD Company profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory…

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in…

CRMD Management team

Name

Position

Tushar Mukherjee

Senior Vice President & Head of Technical Operations

Donna Ucci

Senior Vice President & Head of Global Quality

Matthew T. David M.D.CFO

Executive Vice President & Chief Financial Officer

Elizabeth Masson-Hurlburt B.A.

Executive Vice President and Chief Clinical Strategy & Operations Officer

Kaufman Beth Zelnick Esq.

EVice President, Chief Legal, Compliance Officer & Corporate Secretary

Erin Mistry

Executive Vice President & Chief Commercial Officer

Joseph Todisco MBACEO

Chief Executive Officer & Director

Name

Position

Tushar Mukherjee

Senior Vice President & Head of Technical Operations

Donna Ucci

Senior Vice President & Head of Global Quality

Matthew T. David M.D.CFO

Executive Vice President & Chief Financial Officer

Elizabeth Masson-Hurlburt B.A.

Executive Vice President and Chief Clinical Strategy & Operations Officer

Kaufman Beth Zelnick Esq.

EVice President, Chief Legal, Compliance Officer & Corporate Secretary

Erin Mistry

Executive Vice President & Chief Commercial Officer

Joseph Todisco MBACEO

Chief Executive Officer & Director

Management Team

Tushar Mukherjee

Senior Vice President & Head of Technical Operations

Donna Ucci

Senior Vice President & Head of Global Quality

Matthew T. David M.D.CFO

Executive Vice President & Chief Financial Officer

Elizabeth Masson-Hurlburt B.A.

Executive Vice President and Chief Clinical Strategy & Operations Officer

Kaufman Beth Zelnick Esq.

EVice President, Chief Legal, Compliance Officer & Corporate Secretary

Erin Mistry

Executive Vice President & Chief Commercial Officer

Joseph Todisco MBACEO

Chief Executive Officer & Director

Management

Tushar Mukherjee

Senior Vice President & Head of Technical Operations

Donna Ucci

Senior Vice President & Head of Global Quality

Matthew T. David M.D.CFO

Executive Vice President & Chief Financial Officer

Elizabeth Masson-Hurlburt B.A.

Executive Vice President and Chief Clinical Strategy & Operations Officer

Kaufman Beth Zelnick Esq.

EVice President, Chief Legal, Compliance Officer & Corporate Secretary

Erin Mistry

Executive Vice President & Chief Commercial Officer

Joseph Todisco MBACEO

Chief Executive Officer & Director

Total 7 executives

CRMD Frequently asked questions

What is CorMedix Inc. (CRMD) Stock Price?

Current stock price of CorMedix Inc. (CRMD) stock is $8.610. The stock price is +2.74% higher in the session. The intraday range can be seen from this page. Volume of CorMedix Inc. (CRMD) stock is 1.10M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the CorMedix Inc. (CRMD) stock price going up or down today?

The stock price of CorMedix Inc. (CRMD) can change with earnings, company news, and overall market sentiment. CorMedix Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the CorMedix Inc. stock expensive at its current price?

Whether CorMedix Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRMD on this page is 4.56. EPS on this page is 1.89. Compare those figures with peers and growth expectations before deciding if the current CorMedix Inc. price is justified.

How has the stock price of CorMedix Inc. (CRMD) performed historically?

Historical performance for CorMedix Inc. (CRMD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRMD reacted to past earnings and market events.

Should I buy CorMedix Inc. (CRMD) stock, at this price?

Buying CorMedix Inc. (CRMD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.